Literature DB >> 27160703

Rho Kinase Inhibition Is Essential During In Vitro Neurogenesis and Promotes Phenotypic Rescue of Human Induced Pluripotent Stem Cell-Derived Neurons With Oligophrenin-1 Loss of Function.

Claudia Compagnucci1, Sabina Barresi1, Stefania Petrini2, Pierre Billuart3, Giorgia Piccini4, Pietro Chiurazzi5, Paolo Alfieri4, Enrico Bertini1, Ginevra Zanni6.   

Abstract

UNLABELLED: : Rho-GTPases have relevant functions in various aspects of neuronal development, such as differentiation, migration, and synaptogenesis. Loss of function of the oligophrenin-1 gene (OPHN1) causes X-linked intellectual disability with cerebellar hypoplasia and leads to hyperactivation of the rho kinase (ROCK) pathway. ROCK mainly acts through phosphorylation of the myosin phosphatase targeting subunit 1, triggering actin-myosin contractility. We show that during in vitro neurogenesis, ROCK activity decreases from day 10 until terminal differentiation, whereas in OPHN1-deficient human induced pluripotent stem cells (h-iPSCs), the levels of ROCK are elevated throughout differentiation. ROCK inhibition favors neuronal-like appearance of h-iPSCs, in parallel with transcriptional upregulation of nuclear receptor NR4A1, which is known to induce neurite outgrowth. This study analyzed the morphological, biochemical, and functional features of OPHN1-deficient h-iPSCs and their rescue by treatment with the ROCK inhibitor fasudil, shedding light on the relevance of the ROCK pathway during neuronal differentiation and providing a neuronal model for human OPHN1 syndrome and its treatment. SIGNIFICANCE: The analysis of the levels of rho kinase (ROCK) activity at different stages of in vitro neurogenesis of human induced pluripotent stem cells reveals that ROCK activity decreases progressively in parallel with the appearance of neuronal-like morphology and upregulation of nuclear receptor NR4A1. These results shed light on the role of the ROCK pathway during early stages of human neurogenesis and provide a neuronal stem cell-based model for the treatment of OPHN1 syndrome and other neurological disorders due to ROCK dysfunction. ©AlphaMed Press.

Entities:  

Keywords:  In vitro neurogenesis; Oligophrenin-1; ROCK inhibitors (fasudil, Y-27632); Rho-kinase signaling

Mesh:

Substances:

Year:  2016        PMID: 27160703      PMCID: PMC4922854          DOI: 10.5966/sctm.2015-0303

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  32 in total

Review 1.  Rho GTPases in neuronal morphogenesis.

Authors:  L Luo
Journal:  Nat Rev Neurosci       Date:  2000-12       Impact factor: 34.870

2.  The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase.

Authors:  Jost Leemhuis; Stephanie Boutillier; Gudula Schmidt; Dieter K Meyer
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

3.  Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation.

Authors:  P Billuart; T Bienvenu; N Ronce; V des Portes; M C Vinet; R Zemni; H Roest Crollius; A Carrié; F Fauchereau; M Cherry; S Briault; B Hamel; J P Fryns; C Beldjord; A Kahn; C Moraine; J Chelly
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

4.  Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.

Authors:  Tetsuya Seko; Masaaki Ito; Yasuko Kureishi; Ryuji Okamoto; Nobuyuki Moriki; Katsuya Onishi; Naoki Isaka; David J Hartshorne; Takeshi Nakano
Journal:  Circ Res       Date:  2003-02-06       Impact factor: 17.367

5.  Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF.

Authors:  Jing Ding; Jie-Zhong Yu; Qin-Ying Li; Xin Wang; Chuan-Zhen Lu; Bao-Guo Xiao
Journal:  Brain Behav Immun       Date:  2009-05-15       Impact factor: 7.217

6.  Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells.

Authors:  Hui Zeng; Min Guo; Kristen Martins-Taylor; Xiaofang Wang; Zheng Zhang; Jung Woo Park; Shuning Zhan; Mark S Kronenberg; Alexander Lichtler; Hui-Xia Liu; Fang-Ping Chen; Lixia Yue; Xue-Jun Li; Ren-He Xu
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

7.  Rho-associated coiled kinase inhibitor Y-27632 promotes neuronal-like differentiation of adult human adipose tissue-derived stem cells.

Authors:  Zhong-wen Xue; Xiao-ming Shang; Hong Xu; Song-hui Lü; Tian-wei Dong; Chao-hui Liang; Yuan Yuan
Journal:  Chin Med J (Engl)       Date:  2012-09       Impact factor: 2.628

8.  The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors.

Authors:  Nael Nadif Kasri; Akiko Nakano-Kobayashi; Roberto Malinow; Bo Li; Linda Van Aelst
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

Review 9.  Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.

Authors:  Niko Hensel; Sebastian Rademacher; Peter Claus
Journal:  Front Neurosci       Date:  2015-06-02       Impact factor: 4.677

10.  Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia.

Authors:  G Zanni; Y Saillour; M Nagara; P Billuart; L Castelnau; C Moraine; L Faivre; E Bertini; A Durr; A Guichet; D Rodriguez; V des Portes; C Beldjord; J Chelly
Journal:  Neurology       Date:  2005-10-12       Impact factor: 9.910

View more
  11 in total

Review 1.  Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond.

Authors:  N J Schork; K Nazor
Journal:  Adv Genet       Date:  2017-07-25       Impact factor: 1.944

2.  ROCK/PKA Inhibition Rescues Hippocampal Hyperexcitability and GABAergic Neuron Alterations in a Oligophrenin-1 Knock-Out Mouse Model of X-Linked Intellectual Disability.

Authors:  Irene Busti; Manuela Allegra; Cristina Spalletti; Chiara Panzi; Laura Restani; Pierre Billuart; Matteo Caleo
Journal:  J Neurosci       Date:  2020-02-25       Impact factor: 6.167

3.  Systematic Comparison of Retinal Organoid Differentiation from Human Pluripotent Stem Cells Reveals Stage Specific, Cell Line, and Methodological Differences.

Authors:  Carla B Mellough; Joseph Collin; Rachel Queen; Gerrit Hilgen; Birthe Dorgau; Darin Zerti; Majed Felemban; Kathryn White; Evelyne Sernagor; Majlinda Lako
Journal:  Stem Cells Transl Med       Date:  2019-03-27       Impact factor: 6.940

4.  In Vitro Differentiation of Human Skin-Derived Cells into Functional Sensory Neurons-Like.

Authors:  Adeline Bataille; Raphael Leschiera; Killian L'Hérondelle; Jean-Pierre Pennec; Nelig Le Goux; Olivier Mignen; Mehdi Sakka; Emmanuelle Plée-Gautier; Cecilia Brun; Thierry Oddos; Jean-Luc Carré; Laurent Misery; Nicolas Lebonvallet
Journal:  Cells       Date:  2020-04-17       Impact factor: 6.600

Review 5.  Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.

Authors:  Ewelina Latoszek; Magdalena Czeredys
Journal:  Front Cell Dev Biol       Date:  2021-04-01

6.  Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced Model.

Authors:  Pei-Lun Lai; Chi-Hou Ng; Chia-Hsin Wu; Chien-Ying Lai; Scott C Schuyler; Vicki Wang; Hsuan Lin; Yueh-Chang Lee; Ming-Hsi Chuang; Chang-Huan Yang; Wei-Ju Chen; Hsiao-Chun Huang; Jean Lu
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

Review 7.  Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities.

Authors:  Carla Liaci; Mattia Camera; Giovanni Caslini; Simona Rando; Salvatore Contino; Valentino Romano; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

8.  Repulsive Guidance Molecule A Suppresses Adult Neurogenesis.

Authors:  Toke Jost Isaksen; Yuki Fujita; Toshihide Yamashita
Journal:  Stem Cell Reports       Date:  2020-04-02       Impact factor: 7.765

9.  Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson's Disease.

Authors:  Yilin Tang; Linlin Han; Xiaochen Bai; Xiaoniu Liang; Jue Zhao; Fang Huang; Jian Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-23       Impact factor: 2.570

Review 10.  Rho Kinases in Embryonic Development and Stem Cell Research.

Authors:  Jianjian Shi; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-01-19       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.